Status:

COMPLETED

Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations

Lead Sponsor:

University of Michigan

Collaborating Sponsors:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Pulmonary Disease, Chronic Obstructive

Lung Diseases

Eligibility:

All Genders

40-80 years

Brief Summary

The purpose of this study is to determine whether there is a statistical association between the changes from baseline in the levels of two cytokines interleukin (IL)-17A and IL-6 in the sputum of pat...

Detailed Description

BACKGROUND: COPD is one of the most pressing healthcare problems facing our nation. AE-COPD is responsible for the bulk of healthcare costs and much of the morbidity and decline in health status amon...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Diagnosis of COPD (following American Thoracic Society guidelines) and/or chronic bronchitis
  • Forced Expiratory Volume in 1 second of less than 70% predicted value after bronchodilator
  • Current or former smokers with more than 20 pack-years
  • Daily productive cough for 3 months of the year for 2 consecutive years
  • At least one AE-COPD requiring medical attention in each year for the previous 3 years
  • Willingness to participate in follow-up studies defined in the protocol
  • Exclusion criteria:
  • Unstable cardiovascular disease
  • Other systemic disease in which survival of more than 2 years is unlikely
  • Mental incompetence or active psychiatric illness
  • Currently taking more than 20 mg/day of Prednisone
  • Participation in another experimental protocol within 6 weeks of study entry
  • Asthma
  • Cystic fibrosis
  • Clinically significant bronchiectasis
  • Lung cancer
  • Other inflammatory or fibrotic lung disease

Exclusion

    Key Trial Info

    Start Date :

    September 1 2005

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    September 1 2010

    Estimated Enrollment :

    10 Patients enrolled

    Trial Details

    Trial ID

    NCT00281216

    Start Date

    September 1 2005

    End Date

    September 1 2010

    Last Update

    January 29 2016

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Michigan at Ann Arbor

    Ann Arbor, Michigan, United States, 48105